|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2024 | Cancer therapy-related vaginal toxicity: its prevalence and assessment methods-a systematic review | CLAES, Marithe; Tuts, L.; ROBIJNS, Jolien; Mulders, K.; van de Werf, E.; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 2 | 2024 | Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity | HAESEN, Sibren; JAGER, Manon Marie; Brillouet, Aline; DE LAAT, Iris; VASTMANS, Lotte; VERGHOTE, Eline; DELAET, Anouck; D'HAESE, Sarah; HAMAD, Ibrahim; KLEINEWIETFELD, Markus; MEBIS, Jeroen; MULLENS, Wilfried; LAMBRICHTS, Ivo; WOLFS, Esther; DELUYKER, Dorien; BITO, Virginie | Journal Contribution | A1 |
| 3 | 2023 | Steroid-dependent pericarditis following anti-PD1 immunotherapy in a metastatic melanoma patient: a case report | Verhaert, Marthe; MEBIS, Jeroen; Aspeslagh, Sandrine; von Kemp, Berlinde; Rossi, Valentina; Komorovsky, Roman; Gambaro, Alessia; Kovacs, Boldizsar; Peverelli, Marta; Jathanna, Nikesh | Journal Contribution | A1 |
| 4 | 2023 | Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study | Decoster, L.; Aftimos, P. G.; Rottey, S.; Prenen, H.; Collignon, J. J.; MEBIS, Jeroen; Canon, J-L.; Fastenaekels, V.; Cappoen, N.; Joris, S. R.; De Greve, J. | Journal Contribution | M |
| 5 | 2023 | GeNeo: Agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative | Aftimos, P. G.; Punie, K.; Decoster, L.; de Lummen, C. Van Marcke; Hebrant, A.; Raicevic, G.; Van Valckenborgh, E.; MAES, Brigitte; Maetens, J.; Collignon, J. J.; van den Mooter, T. F. A.; Fried-Vermeij, J.; Demey, W.; Tejpar, S.; Peeters, M.; Canon, J-L.; Lybaert, W.; MEBIS, Jeroen; Rottey, S.; De Greve, J. | Journal Contribution | M |
| 6 | 2023 | Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II study | Joris, S. R.; Denys, H.; Collignon, J. J.; Rasschaert, M.; de Roodenbeke, D. T'Kint; Duhoux, F. P.; Canon, J-L.; Tejpar, S.; MEBIS, Jeroen; Decoster, L.; Aftimos, P. G.; De Greve, J. | Journal Contribution | M |
| 7 | 2023 | The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Pierson, Maud; Lenaerts, Melissa; MEBIS, Jeroen | Journal Contribution | A1 |
| 8 | 2023 | Evaluation of a novel skin care product for the management of chemotherapy– related dermatologic toxicities: A quasi-experimental study | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Tuts, Laura; Lenaerts, Melissa; Wessels, Tim; Requilé, Annelies; Luyten, Daisy; Verheezen, Jolanda; Joosens, Eric; MEBIS, Jeroen | Journal Contribution | A1 |
| 9 | 2023 | Photobiomodulation in the management of chemotherapy-induced peripheral neuropathy: a randomized, controlled trial | CLAES, Marithe; LODEWIJCKX, Joy; Hermans, S.; Peeters, P.; MEBIS, Jeroen; ROBIJNS, Jolien | Journal Contribution | M |
| 10 | 2023 | A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial | ROBIJNS, Jolien; Van Bever, Leen; Hermans, Sanne; CLAES, Marithe; LODEWIJCKX, Joy; Lenaerts, Melissa; Tuts, Laura; Vandaele, Eline; Vinken, Evelien; Noé, Leen; Verboven, Katleen; MAES, Annelies; Van de Velde, Anne-Sophie; BULENS, Paul; Bulens, Philippe; Van den Bergh, Laura; MEBIS, Jeroen | Journal Contribution | A1 |
| 11 | 2022 | Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group | Vergote, I; Van Nieuwenhuysen, E; De Waele, S; Vulsteke, C; Lamot, C; Van den Bulck, H; CLAES, Nele; Graas, MP; DEBROCK, Guy; Spoormans, I; Vuylsteke, P; Honhon, B; Verhoeven, D; Daan De Maeseneer; Dirix, L; MEBIS, Jeroen; Vroman, P; Denys, H; Mena, CM; Pelgrims, G; Van Steenberghe, M; van Gorp, T; Gennigens, C | Journal Contribution | A1 |
| 12 | 2022 | PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment | Thouvenin, J.; Van Marcke, C.; Decoster, L.; Raicevic, G.; Punie, K.; Vandenbulcke, M.; Salgado, R.; Van Valckenborgh, E.; Maes, B.; Joris, S.; Vander Steichel, D.; Vranken, K.; Jacobs , S.; Dedeurwaerdere, F.; Martens, G.; Devos, H.; Duhoux, F. P.; Rasschaert, M.; Pauwels , P.; Geboes, K.; Collignon, J.; Tejpar, S.; Canon, J-L; Peeters, M.; Rutten, A.; Van de Mooter, T.; Vermeij, J.; Schrijvers, D.; Demey, W.; Lybaert, W.; Van Huysse, J.; MEBIS, Jeroen; Awada, A.; Claes, K. B. M.; Hebrant, A.; Van der Meulen, J.; Delafontaine, B.; Vanden Bempt, I; Maetens, J.; de Hemptinne, M.; Rottey, S.; Aftimos, P.; De Greve, J. | Journal Contribution | A1 |
| 13 | 2022 | Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; MEBIS, Jeroen | Journal Contribution | M |
| 14 | 2022 | Photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Hermans, S.; MEBIS, Jeroen | Journal Contribution | M |
| 15 | 2022 | The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Evens, Stijn; Swinnen, Laura; Lenders, Hilde; Bortels, Sandra; Nassen, Wendy; Hilkens, Ruth; Raymakers, Liesbeth; Snoekx, Sylvana; Hermans, Sylvia; MEBIS, Jeroen | Journal Contribution | A1 |
| 16 | 2022 | Photobiomodulation Therapy in Management of Cancer Therapy-Induced Side Effects: WALT Position Paper 2022 | ROBIJNS, Jolien; LODEWIJCKX, Joy; Arany, Praveen; Barasch, Andrei; Jan, Bjordal; Bossi, Paolo; Chilles, Anne; Corby, Patricia; Epstein, Joel; Elad, Sharon; Fekrazad, Reza; Fregnani, Eduardo; Genot, Marie-Thérèse; Ibarra, Ana; Hamblin, Michael; Heiskanen, Vladimir; Hu, Ken; Klastersky, Jean; Lalla, Raj; Latifian, Sofia; Maiya, Arun; MEBIS, Jeroen; Migliorati, Cesar; Milstein, Dan; Murhpy, Barbara; Raber-Durlacher, Judith; Roseboom, Hendrik; Sonis, Stephen; Treister, Nathaniel; Zadik, Yehuda; Bensadoun, René-Jean | Journal Contribution | A1 |
| 17 | 2022 | Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMIS- HEAD trial)" by He et al | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes , Stefan; Van Bever, Leen; Pannekoeke , Luc; Censabella, Sandrine; Busse, Lore; COLSON, Dora; Kaminski, Iris; Broux, Victoria; Puts , Sofie; Vanmechelen, Sofie; Timmermans, An; Noe, Leen; BULENS, Paul; Govers, Mieke; Maes, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 18 | 2022 | A long‐term follow‐up of early breast cancer patients treated with photobiomodulation during conventional fractionation radiotherapy in the prevention of acute radiation dermatitis | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Lenaerts, Melissa; Van Bever, Leen; Claes, Stefan; Pannekoeke, Luc; Verboven, Katleen; Noé, Leen; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 19 | 2022 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole‐breast irradiation (LABRA trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Puts, Sofie; Timmermans, An; Noe, Leen; Vanmechelen, Sofie; Govers, Mieke; Van de Werf, Evelyn; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen; Claes, Stefan; Pannekoeke, Luc | Journal Contribution | A1 |
| 20 | 2022 | The perspective of patients on the use of telemedicine in cardiovascular care | Knaepen, L.; Essarti, H.; Vervoort, Y.; Driesen , K.; MEBIS, Jeroen; Vandenberk, F.; Vanoppen, A.; DENDALE, Paul; DESTEGHE, Lien; HEIDBUCHEL, Hein | Journal Contribution | M |
| 21 | 2021 | A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis | Brufsky, A.; Kim, S. B.; Zvirbule, Z.; Eniu, A.; MEBIS, Jeroen; Sohn, J. H.; Wongchenko, M.; Chohan, S.; Amin, R.; Yan, Y.; McNally, V; Miles, D.; Loi, S. | Journal Contribution | A1 |
| 22 | 2021 | A DIGITAL AUTOMATED HEALTH MONITORING SYSTEM FOR ONCOLOGY PATIENTS DURING THE COVID-19 PANDEMIC: PRACTICAL ISSUES AND LESSONS FOR THE FUTURE | ROBIJNS, Jolien; LODEWIJCKX, Joy; WIJNEN, Katrien; Snoekx, Sylvana; Hilkens, Ruth; Bortels, Sandra; Lenders, Hilde; Nassen, Wendy; Dewaele, Elien; Luyten, D.; Joosens, Eric; Requilé, Annelies; Verheezen, Yolanda; Wessels, Tim; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 23 | 2021 | PHOTOBIOMODULATION THERAPY CAN PREVENT THE DEVELOPMENT OF SEVERE ACUTE RADIODERMATITIS IN HEAD AND NECK CANCER PATIENTS: A MULTICENTRIC, RANDOMIZED CONTROLLED TRIAL | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | M |
| 24 | 2021 | THE SAFE USE OF PHOTOBIOMODULATION THERAPY IN AN ONCOLOGIC SETTING | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | M |
| 25 | 2021 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; Timmermans, An; Noé, Leen; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 26 | 2021 | THE USE OF PHOTOBIOMODULATION THERAPY FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: PRELIMINARY RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL | LODEWIJCKX, Joy; ROBIJNS, Jolien; Hermans, S; MEBIS, Jeroen | Journal Contribution | M |
| 27 | 2021 | Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 28 | 2021 | Response to the Letter to the editor by Donnelly et al. regarding the article “Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)” | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Govers, Mieke; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; BULENS, Paul; Vanmechelen, Sofie; MAES, Annelies; MEBIS, Jeroen; Claes, Stefan | Journal Contribution | A1 |
| 29 | 2021 | Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study | Joris, S.; Denys, H.; Martin, M.; de Roodenbeke, D. t'Kint; Duhoux, F.; Berchem, G.; Punie, K.; Bols, A.; MEBIS, Jeroen; Canon, J-L.; Decoster, L.; De Greve, J. | Journal Contribution | M |
| 30 | 2020 | Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results | Catala, Gaetan; MEBIS, Jeroen; Jerusalem, Guy; Verhoeven, Didier; Awada, Ahmad; Bols, Alain; Somers, Luc; Van Den Broeck, Anke; Duhoux, Francois P; Machiels, Jean-Pascal | Journal Contribution | A1 |
| 31 | 2020 | PRELIMINARY RESULTS OF A MULTICENTRIC, PLACEBO-CONTROLLED CLINICAL TRIAL | ROBIJNS, Jolien; LODEWIJCKX, Joy; Puts , Sofie; Claes, Stefan; Van Bever, Leen; Busse, Lore; Colson , Dora; Kaminski, Iris; Broux, Victoria; MAES, Annelies; BULENS, Paul; Noe, Leen; Brosens, Marc; Govers, Mieke; Timmermans, An; MEBIS, Jeroen | Journal Contribution | M |
| 32 | 2020 | Photobiomodulation Therapy for the Management of Chemotherapy-Induced Peripheral Neuropathy: An Overview | LODEWIJCKX, Joy; ROBIJNS, Jolien; Bensadoun, René-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 33 | 2020 | A Narrative Review on the Use of Photobiomodulation Therapy for the Prevention and Management of Acute Radiodermatitis: Proposed Mechanisms, Current Clinical Outcomes, and Preliminary Guidance for Clinical Studies | ROBIJNS, Jolien; LODEWIJCKX, Joy; Bensadoun, Rene-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 34 | 2019 | Quality of life, fatigue, and subjective cognitive functioning immediately and 6 months after adjuvant chemotherapy in breast cancer patients | MEBIS, Jeroen; Censabella, S; Engels, Sofie; Van Marsenille, C.; ORYE, Guy; MARQUETTE, Sophie; Vansteelant, L.; Luyten, D.; MAES, Annelies; Noé, L; BULENS, Paul | Journal Contribution | M |
| 35 | 2019 | Systematic screening and assessment of psychosocial well-being and care needs of people with cancer | SCHOUTEN, Bojoura; Avau, Bert; Bekkering, Geertruida; Vankrunkelsven, Patrick; MEBIS, Jeroen; HELLINGS, Johan; Van Hecke, Ann | Journal Contribution | A1 |
| 36 | 2019 | Low-level laser therapy for the prevention of acute radiodermatitis in breast cancer patients: a randomized, placebo-controlled clinical trial (TRANSDERMIS trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Censabella, Sandrine; Claes, Stefan; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | M |
| 37 | 2019 | Photobiomodulation therapy for acute radiodermatitis | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | A1 |
| 38 | 2019 | Letter to the Editor concerning the article “Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer | ROBIJNS, Jolien; Censabella, S; Claes, S; Pannekoeke, L; Bussé, L; Colson, D; Kaminski, I; Broux, V; LODEWIJCKX, Joy; Puts, S; BULENS, Paul; MAES, Annelies; Noé, L; Brosens, M; Timmermans, A; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | A1 |
| 39 | 2018 | Photobiomodulation therapy prevents severe acute radiodermatitis: a randomized, placebo-controlled trial in breast cancer patients with clinical and objective outcome measures | ROBIJNS, Jolien; Censabella, S.; Claes, S.; Pannekoeke, L.; Bussé, L.; Colson, D.; Kaminksi, I.; BULENS, Paul; MAES, Annelies; Noé, L.; Brosens, M.; Timmermans, A.; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | M |
| 40 | 2018 | Photobiomodulation prevents acute radiodermatitis: final results of a RCT in bre ast cancer patients | ROBIJNS, Jolien; Censabella, S.; Claes, S.; Pannekoeke, L.; Busse, L.; Kaminksi, I.; Colson, D.; MAES, Annelies; BULENS, Paul; Noe, L.; Brosens, M.; Timmermans, A.; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | M |
| 41 | 2018 | Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial). | ROBIJNS, Jolien; Censabella, Sandrine; Claes, Stefan; Pannekoeke, Luc; Bussé, Lore; Colson, Dora; Kaminski, Iris; BULENS, Paul; MAES, Annelies; Noé, Leen; Brosens, Marc; Timmermans, An; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | A1 |
Loading...
5
0
5
0
false